Nature's Sunshine Products, Inc.
Rank #4Capital ReturnNATR · Nasdaq · Consumer Defensive
Nature's Sunshine Products, Inc. (NATR) — Rank #4 by gross profitability (GP/assets 1.34) · ROE 11.5% · Piotroski F-Score N/A.
As-of 2026-09-15 · CIK 0000275053 · all metrics point-in-time as of the filing date.
About
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally.
Show moreShow less
The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser. In addition, the company provides weight management products, such as meal replacements and products that increase caloric burn rate. It offers its products under the Nature's Sunshine and Synergy Worldwide brands through its network of independent consultants to customers. Nature's Sunshine Products, Inc.
was founded in 1972 and is headquartered in Lehi, Utah.
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- State
- UT
- Filer Category
- Accelerated filerSmaller reporting company
- Fiscal Year End
- December 31
- Website
- naturessunshine.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-03-10 | 2024-12-31filed 2025-03-11 | 2023-12-31filed 2024-03-12 | 2022-12-31filed 2023-03-16 |
|---|---|---|---|---|
| Revenue | 480.1 | 454.4 | 445.3 | 421.9 |
| Revenue growth (YoY) | 5.7% | 2.0% | 5.5% | -5.0% |
| Cost of revenue | 132.4 | 129.7 | 124.2 | 122.2 |
| Gross profit | 347.7 | 324.7 | 321.1 | 299.8 |
| Gross margin | 72.4% | 71.5% | 72.1% | 71.0% |
| Selling, general & administrative | 178.4 | 164.0 | 167.1 | 153.1 |
| Research & development | 1.9 | 1.7 | 1.6 | 1.5 |
| Operating income | 24.7 | 20.1 | 18.7 | 16.3 |
| Operating margin | 5.2% | 4.4% | 4.2% | 3.9% |
| Interest expense | — | — | 0.1 | 0.2 |
| Pre-tax income | 29.8 | 18.4 | 20.2 | 15.2 |
| Income tax expense | 9.4 | 10.5 | 3.8 | 14.7 |
| Net income | 19.5 | 7.7 | 15.1 | (0.4) |
| Net margin | 4.1% | 1.7% | 3.4% | -0.1% |
| EPS (basic) | $1.08 | $0.41 | $0.79 | -$0.02 |
| EPS (diluted) | $1.06 | $0.40 | $0.77 | -$0.02 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?